Overexpression of TWIST1, one of the key transcription factors in EMT, has beenshown to cause EGFR mutant NSCLC cells to become resistant to the EGFRinhibitors erlotinib and osimertinib [204]. This evidence concerns the gene TWIST1 and non-small cell lung carcinoma.